Dolly the sheep health fears unfounded: experts

Image
Press Trust of India London
Last Updated : Nov 24 2017 | 2:25 PM IST
Dolly the sheep - the first mammal cloned from an adult cell - did not develop early arthritis or age prematurely, a study has found.
Experts at the University of Nottingham and University of Glasgow in the UK found that original concerns that cloning caused early-onset osteoarthritis (OA) in Dolly are unfounded.
The findings, published in the journal Scientific Reports, show that the skeletons, stored in the collections of National Museums Scotland in Edinburgh, bear radiographic OA similar to that observed in naturally conceived sheep and healthy aged clones.
"Our findings of last year appeared to be at odds with original concerns surrounding the nature and extent of osteoarthritis in Dolly - who was perceived to have aged prematurely," said Kevin Sinclair, Professor at the University of Nottingham.
"Yet no formal, comprehensive assessment of osteoarthritis in Dolly was ever undertaken. We therefore felt it necessary to set the record straight," said Sinclair.
The four Nottingham 'Dollies' - Debbie, Denise, Dianna and Daisy - were derived from the cell line that gave rise to Dolly.
They originated from studies undertaken by Professor Keith Campbell between 2005 and 2007 which sought to improve the efficiency of somatic-cell nuclear transfer (SCNT).
They concluded that the Nottingham Dollies had aged normally with no clinical signs of OA.
They had radiographic evidence of only mild or, in one case, moderate OA.
Their results, published last year in the journal Nature Communications, were in apparent stark contrast to Dolly the Sheep's diagnosis of early onset OA which led to scientific concern and media debate over the possibility of early-onset- age-related diseases in cloned animals.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 24 2017 | 2:25 PM IST

Next Story